Fil LTD Cytom X Therapeutics, Inc. Transaction History

Fil LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$9.35 - $11.41 $1.06 Million - $1.29 Million	-112,956 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$9.5 - $19.16 $4.31 Million - $8.7 Million	-454,036 Reduced 80.08%	112,956 $1.21 Million
Q4 2018 Feb 13, 2019	BUY	$12.69 - $18.61 $67,028 - $98,298	5,282 Added 0.94%	566,992 $8.56 Million
Q3 2018 Nov 09, 2018	BUY	$18.04 - $26.41 $30,577 - $44,764	1,695 Added 0.3%	561,710 $10.4 Million
Q2 2018 Aug 10, 2018	BUY	$21.38 - $29.68 $2.78 Million - $3.86 Million	130,090 Added 30.26%	560,015 $12.8 Million
Q1 2018 May 14, 2018	BUY	$21.76 - $34.22 $2.5 Million - $3.93 Million	114,962 Added 36.5%	429,925 $12.2 Million
Q4 2017 Feb 12, 2018	BUY	$19.0 - $23.09 $3.8 Million - $4.62 Million	200,058 Added 174.11%	314,963 $6.65 Million
Q3 2017 Nov 13, 2017	BUY	$13.53 - $18.17 $1.55 Million - $2.09 Million	114,905	114,905 $2.09 Million

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.